Key facts
- It has raised $93.0M; the latest was Later Stage VC in Feb 2025.
- Notable investors include National Institutes of Health, CE-Ventures, Mission Cure Capital.
- Status: Acquired/Merged (Operating Subsidiary).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Cedars-Sinai
- ·The full record, as it builds
Funding rounds
No funding rounds for Cedars-Sinai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cedars-Sinai
Operator of a healthcare facility platform intended to provide comprehensive medical care and advanced treatments. The company offers a broad range of specialties, cutting-edge research, and a commitment to patient care, enabling individuals seeking healthcare to receive personalized and effective treatment.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 1902
- Employees
- 17,000
- Website
- cedars-sinai.org/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Cedars-Sinai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cedars-Sinai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cedars-Sinai in its N-PORT filings yet. We sweep new filings monthly.